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We report the updated classiﬁcation of primary immunodeﬁciency diseases, compiled by
the ad hoc Expert Committee of the International Union of Immunological Societies. As
compared to the previous edition, more than 15 novel disease entities have been added
in the updated version. For each disorders, the key clinical and laboratory features are pro-
vided. This updated classiﬁcation is meant to help in the diagnostic approach to patients
with these diseases.
Keywords: primary immunodeﬁciency diseases
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The International Union of Immunological Societies (IUIS)
Expert Committee on Primary Immunodeﬁciency met in New
York City, May 31–June 1, 2011 to update the classiﬁcation of
humanprimaryimmunodeﬁciencies(PIDs).Noveldevelopments
ingenediscoveryandincreasedknowledgeinthemechanismsthat
govern immune system development and function have resulted
in the identiﬁcation of several novel PIDs in the last 2years.
The classiﬁcation of primary immunodeﬁciencies (PIDs) pro-
vides a framework to help in the diagnostic approach to patients.
As in recent classiﬁcations, eight major groups of PIDs have been
included in the Tables; however the order of the Tables has been
changed with Table 2 now describing the “Well-deﬁned syn-
dromes with immunodeﬁciency” (previously Table 3)t or e ﬂ e c t
the immunological similarity between the disorders included in
this Table and those in Table 1, “Combined immunodeﬁcien-
cies.”
Any classiﬁcation of human disorders is somewhat arbitrary,
and the classiﬁcation of PIDs is no exception. Some disorders
mightwellbelongtomorethanonegroup.CD40liganddeﬁciency,
for example, is reported both in Tables 1 and 3 (“Predominantly
antibodydeﬁciencies”),toreﬂectthefactsthatfailedBcellisotype
switching was historically the most prominent feature of this con-
dition (originally named Hyper-IgM syndrome) and that some
patients survive into adulthood without signiﬁcant opportunistic
infections and do well with only immunoglobulin replacement
therapy. Explanatory notes provided after each Table offer addi-
tional information (particularly where a condition appears in
morethanoneTable)andindicatewhichnewdisordershavebeen
added to that Table.
Although this updated classiﬁcation reports on the most typ-
ical immunological ﬁndings and associated clinical and genetic





in Man (OMIM) publicly accessible database (www.omim.org) of
human genetic disorders. It is suggested that the reader consult
this regularly updated and fully referenced resource.
The prevalence of the various PIDs varies in different coun-
tries. For this reason, in this new classiﬁcation, we have elected
to avoid giving a comment on the relative frequency of PID dis-
orders. However, an asterisk has been placed in the ﬁrst column,
after the disease name, to identify disorders for which fewer than
10 unrelated cases have been reported in the literature. Some of
these forms of PID can be considered extremely rare. Others have
only recently been identiﬁed and it may be that more patients will
be detected over time.
Finally, it is increasingly recognized that different mutations
in the same gene may result in different phenotypes and may
be associated with different patterns of inheritance. This concept
of clinical, immunological, and genetic heterogeneity is assuming
foremostimportance.Notesinthetextorinthefootnotesidentify
such heterogeneity, when known.
The scope of the IUIS Expert Committee on Primary Immun-
odeﬁciency is to increase awareness, facilitate recognition, and
promote optimal treatment for patients with Primary Immunod-
eﬁciencydisordersworldwide.Forthisreason,inadditiontoperi-
odically revising the Classiﬁcation of PIDs,the Expert Committee
is also actively involved in the development of diagnostic criteria
and in providing, upon request, advice with regard to therapeutic
guidelines.
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Decreased Markedly decreased NK cells;
leaky cases may present with
low to normalT and/or NK
cells or Omenn syndrome
XL Defect in γ chain of receptors








Decreased Markedly decreased NK cells;
leaky cases may present with
variableT and/or NK cells




















Normal Decreased Normal NK cells
Noγ/δT cells
AR Defect in CD3δ, CD3ε,o r









Normal Decreased Detectable thymus AR Defective thymic egress ofT














AR Defective VDJ recombination;
defect of recombinase













AR Defective VDJ recombination;









Decreased (Widely studied scid mouse
defect)












Decreased Deﬁciency ofT, B, and NK
cells with granulocytopenia,
deafness
AR Defective maturation of
lymphoid and myeloid cells



















Decreased NK cells, often
with costochondral junction
ﬂaring, neurological features,
hearing impairment, lung, and
liver manifestations; partial
ADA deﬁciency may lead to
delayed or milder
presentation
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AR Hypomorphic mutations in
RAG1/2, Artemis, IL7Rα,
RMRP , ADA, DNA Ligase IV,
γc, or associated with
DiGeorge syndrome; some





Decreased Decreased Decreased Microcephaly, facial
dysmorphisms, radiation
sensitivity; may present with
Omenn syndrome or with a
delayed clinical onset







Decreased Decreased Decreased Microcephaly, in utero growth
retardation, radiation
sensitivity
























anemia, biliary tract, and liver
disease, opportunistic
infections





















and liver/biliary tract disease,
opportunistic infections
AR Defects in CD40 cause
defective isotype switching





































Normal Normal AR Defects in ZAP-70 signaling
kinase
176947









Normal Normal Autoimmunity, anhydrotic
ectodermic dysplasia,
non-progressive myopathy






Frontiers in Immunology | Primary Immunodeﬁciencies November 2011 | Volume 2 | Article 54 | 4Al-Herz et al. IUIS classiﬁcation of primary immunodeﬁciencies






















Normal Normal Autoimmunity, anhydrotic
ectodermic dysplasia,
non-progressive myopathy










Normal Normal Vasculitis AR Mutations inTAP1,TAP2o r
TAPBP (tapasin) genes giving











Failure to thrive, diarrhea,
respiratory tract infections
AR Mutation in transcription














AR Defects in forkhead box N1
transcription factor encoded
















AD Deletion of chromosome





















sparse hair, bone marrow
failure, autoimmunity,
susceptibility to lymphoma
and other cancers, impaired
spermatogenesis, neuronal
dysplasia of the intestine
AR Mutations in RMRP (RNase
MRP RNA) Involved in
processing of ribosomal RNA,
mitochondrial DNA replication
















zinc-ﬁnger protein and a











AR Defects of STAT5b, impaired
development and function of

















Normal Normal EBV infection, lymphoma;
viral infections, respiratory
and GI infections
XL Mutations in MAGT1,
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extensive cutaneous viral, and
bacterial (staph.) infections,
susceptibility to cancer
AR Defect in DOCK8 243700
XL, X-linked inheritance; AR, autosomal recessive inheritance; AD, autosomal dominant inheritance; SCID, severe combined immune deﬁciency; EBV, Epstein Barr
virus; Ca
++, calcium; MHC, major histocompatibility complex.
*Ten or fewer unrelated cases reported in the literature.
Three disorders have been added toTable 1: DOCK8 deﬁciency, IKAROS deﬁciency, and MAGT1 deﬁciency.
Infants with SCID who have maternal T cells engraftment may have T cells that do not function normally; these cells may cause autoimmune cytopenias or graft
versus host disease. Hypomorphic mutations in several of the genes that cause SCID may result in Omenn syndrome (OS), or “leaky” SCID. Both of these disorders
can be associated with higher numbers ofT cells and reduced rather than absent activation responses when compared with typical SCID caused by null mutations.
A spectrum of clinical ﬁndings including typical SCID, OS, leaky SCID, and granulomas withT lymphopenia can be found in patients with RAG gene defects.R A C 2
deﬁciency is a disorder of leukocyte motility and is reported inTable 5; however, one patient with RAC2 deﬁciency was found to have absentT cell receptor excision
circles (TRECs) by newborn screening, butT cell numbers and mitogen responses were not impaired. For additional syndromic conditions withT cell lymphopenia,
such as DNA repair defects, cartilage hair hypoplasia, IKAROS deﬁciency, and NEMO syndrome, seeTables 2 and 6; however, it should be noted that individuals
with the most severe manifestations of these disorders could have clinical signs and symptoms of SCID. Severe folate deﬁciency (such as with malabsorption due to
defects in folate carrier or transporter genes SLC10A1 or PCFT) and some metabolic disorders, such as methylmalonicaciduria, may present with reversible profound
lymphopenia in addition to their characteristic presenting features.
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nephropathy; bacterial and viral
infections. XL thrombocytopenia
is a mild form of WAS, and XL
neutropenia is caused by
missense mutations in the
GTPase binding domain of WASP

























alpha fetoprotein and X-ray
sensitivity; chromosomal
instability



















































































1, 9, 16; no DNA breaks
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Normal Normal Low IgG Mild motor control and learning
difﬁculties, mild facial



















large deletion (3Mb) in 22q11.2


























hair, bone marrow failure,
autoimmunity, susceptibility to
lymphoma and other cancers,
impaired spermatogenesis,
neuronal dysplasia of the
intestine















fungal infections; may present as



















hair, atopic diathesis, increased













































mutations in STAT 3
(Continued)
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Normal (±) Elevated IgE Susceptibility to intracellular
bacteria (mycobacteria,




Reduced Reduced (±) Elevated IgE,
low IgM
Recurrent respiratory infections;
extensive cutaneous viral and
staphylococcal infections,



































AR Mutations in SP110 235550


























(c) AD-DKC Variable Variable Variable Reticular hyperpigmentation of
the skin, dystrophic nails,
osteoporosis, premalignant
leukokeratosis of the mouth
mucosa, palmar hyperkeratosis,
anemia, pancytopenia
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SCID, severe combined immune deﬁciency; XL, X-linked inheritance; AR, autosomal recessive inheritance; AD, autosomal dominant inheritance; MSMD, Mendelian
susceptibility of mycobacterial disease.
*Ten or fewer unrelated cases reported in the literature.
Four disorders listed inTable 2, complete DiGeorge anomaly, cartilage hair hypoplasia, IKAROS deﬁciency, andAR-HIES caused by DOCK8 deﬁciency, are also included
inTable 1 as they are characterized by strikingT and B cell abnormalities. While not all DOCK8 deﬁcient patients have elevated serum IgE, most have recurrent viral
infections and malignancies as a result of combined immunodeﬁciency. AR-HIES due toTYK2 deﬁciency is also described inTable 6, because of its association with
atypical mycobacterial disease resulting in MSMD. Because Riddle syndrome is caused by mutations in a gene involved in DNA double-strand break repair and is
associated with hypogammaglobulinemia, we have added this rare syndrome toTable 2. Chronic mucocutaneous candidiasis (CMC) has been moved toTable 6.
Autosomal dominant and autosomal recessive forms of Dyskeratosis congenita, caused by mutations of recently identiﬁed genes, have been included in this table.
Finally, we added IKAROS deﬁciency, observed in a single case, a prematurely born infant, who died at the age of 87 days. He had absent B and NK cells and
non-functionalT cells, suggesting combined immunodeﬁciency.
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T a b l e3|P r edominantly antibody deﬁciencies.





1. Severe reduction in all serum immunoglobulin isotypes with profoundly decreased or absent B cells
(a) BTK deﬁciency All isotypes decreased in




normal numbers of pro-B cells
XL Mutations in BTK,a
cytoplasmic tyrosine
kinase activated by
crosslinking of the BCR
300300
(b) μ Heavy chain
deﬁciency
All isotypes decreased Severe bacterial infections;
normal numbers of pro-B cells
AR Mutations in μ heavy
chain
147020
(c) λ5 deﬁciency* All isotypes decreased Severe bacterial infections;
normal numbers of pro-B cells
AR Mutations in λ5; part of
the surrogate light chain
in the pre-BCR
146770
(d) Igα deﬁciency* All isotypes decreased Severe bacterial infections;
normal numbers of pro-B cells
AR Mutations in Igα
(CD79a); part of the
pre-BCR and BCR
112205
(e) Igβ deﬁciency* All isotypes decreased Severe bacterial infections;
normal numbers of pro-B cells
AR Mutations in Igβ
(CD79b); part of the
pre-BCR and BCR
147245
(f) BLNK deﬁciency* All isotypes decreased Severe bacterial infections;
normal numbers of pro-B cells















One or more isotypes may
be decreased
Infections; decreased number of
pro-B cells
Variable May have monosomy 7 ,
trisomy 8, or
dyskeratosis congenita




Low IgG and IgA and/or
IgM
Clinical phenotypes vary: most






(b) ICOS deﬁciency* Low IgG and IgA and/or
IgM
AR Mutations in ICOS 604558
(c) CD19 deﬁciency* Low IgG and IgA and/or
IgM





(d) CD81 deﬁciency* Low IgG, low or normal
IgA, and IgM





(e) CD20 deﬁciency* Low IgG, normal or
elevated IgM, and IgA
AR Mutations in CD20 112210
(Continued)
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(f)TACI deﬁciency Low IgG and IgA and/or
IgM







Low IgG and IgM Variable clinical expression AR Mutations in
TNFRSF13C (BAFF-R)
606269
3. Severe reduction in serum IgG and IgA with normal/elevated IgM and normal numbers of B cells
(a) CD40L deﬁciency IgG and IgA decreased;
IgM may be normal or
increased; B cell numbers














AR Mutations in CD40
(also calledTNFRSF5)
109535
(c) AID deﬁciency IgG and IgA decreased;
IgM increased
Enlarged lymph nodes and
germinal centers
AR Mutations in AICDA
gene
605257
(d) UNG deﬁciency IgG and IgA decreased;
IgM increased
Enlarged lymph nodes and
germinal centers
AR Mutations in UNG 191525
4. Isotype or light chain deﬁciencies with normal numbers of B cells
(a) Ig heavy chain
mutations and deletions
One or more IgG and/or
IgA subclasses as well as
IgE may be absent
May be asymptomatic AR Mutation or
chromosomal deletion
at 14q32
(b) κ chain deﬁciency* All immunoglobulins have
lambda light chain





Reduction in one or more
IgG subclass
Usually asymptomatic; a
minority may have poor antibody




(d) IgA with IgG
subclass deﬁciency
Reduced IgA with
decrease in one or more
IgG subclass





IgA decreased/absent Usually asymptomatic; may have
recurrent infections with poor
antibody responses to
carbohydrate antigens; may have
allergies or autoimmune disease.
A very few cases progress to









Normal Reduced ability to make
antibodies to speciﬁc antigens
Variable Unknown
(Continued)
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numbers of B cells
IgG and IgA decreased Normal ability to make
antibodies to vaccine antigens,
usually not associated with
signiﬁcant infections
Variable Unknown
XL, X-linked inheritance; AR, autosomal recessive inheritance; AD, autosomal dominant inheritance; BTK, Bruton tyrosine kinase; BLNK, B cell linker protein; AID,
activation-induced cytidine deaminase; UNG, uracil-DNA glycosylase; ICOS, inducible costimulator; Ig(κ), immunoglobulin, or κ light chain type.
*Ten or fewer unrelated cases reported in the literature.
Two new autosomal recessive disorders that might previously have been called CVID have been added to Table 3. CD81 is normally co-expressed with CD19 on
the surface of B cells. Like CD19 mutations, mutations in CD81 result in normal numbers of peripheral blood B cells, low serum IgG, and an increased incidence of
glomerulonephritis. A single patient with a homozygous mutation in CD20 has been reported.
Common Variable Immunodeﬁciency Disorders (CVID) include several clinical and laboratory phenotypes that may be caused by distinct genetic and/or environ-
mental factors. Some patients with CVID and no known genetic defect have markedly reduced numbers of B cells as well as hypogammaglobulinemia. Alterations
in TNFRSF13B (TACI) and TNFRSF13C (BAFF-R) sequences may represent disease modifying mutations rather than disease causing mutations. CD40L and CD40
deﬁciency are included in Table 1 as well as this table. A small minority of patients with XLP (Table 4), WHIM syndrome (Table 6), ICF (Table 2), VOD1 (Table 2),
thymoma with immunodeﬁciency (Good syndrome) or myelodysplasia are ﬁrst seen by an immunologist because of recurrent infections, hypogammaglobulinemia,
and normal or reduced numbers of B cells. Patients with GATA2 mutations (Table 5) may have markedly reduced numbers of B cells, as well as decreased monocytes
and NK cells and a predisposition to myelodysplasia but they do not have an antibody deﬁciency.
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Giant lysosomes, low NK, and
CTL activities, elevation of acute
phase markers






Normal Normal Normal Partial albinism, elevation of
acute phase markers,
encephalopathy in some
patients. Low NK and CTL
activities
AR Mutations in RAB27A
encoding a GTPase that
promotes docking of







Normal Normal Normal Partial albinism, increased
bleeding. Neutropenia, low NK,
and CTL activity
AR Mutations in the AP3B1
gene, encoding for the β
subunit of the AP-3 complex
608233




Normal Normal Normal Severe inﬂammation, persistent
fever, cytopenias, splenomegaly.
Hemophagocytosis, decreased
to absent NK and CTL activities
AR Mutations in PRF1; perforin,






Normal Normal Normal Severe inﬂammation, persistent
fever, splenomegaly,
hemophagocytosis, decreased
NK and CTL activities
AR Mutations in UNC13D*
required to prime vesicles for
fusion (*as named in OMIM).
Note that also in OMIM the
“ofﬁcial” name is UNC13D
deﬁciency with the alternative





Normal Normal Normal Severe inﬂammation, persistent
fever, splenomegaly.
Hemophagocytosis, decreased
to absent NK activity
AR Mutations in STX11, required
for fusion of secretory
vesicles with the cell












bowel disease. Decreased NK
and CTL activities with partial
restoration after IL -2 stimulation
AR Mutations in STXBP2,
required for fusion of
secretory vesicles with the




Frontiers in Immunology | Primary Immunodeﬁciencies November 2011 | Volume 2 | Article 54 | 14Al-Herz et al. IUIS classiﬁcation of primary immunodeﬁciencies





























to absent NKT cells
XL Mutations in SH2D1A















XL Mutations in XIAP encoding
an inhibitor of apoptosis
300635




























surface apoptosis receptor; in
addition to germline
mutations, somatic mutations











AD AR Mutations inTNFSF6, ligand






Normal Normal Adenopathies, splenomegaly,
autoimmunity. Defective
lymphocyte apoptosis

































apoptosis following IL -2
withdrawal
Sporadic Somatic mutations in NRAS
encoding a GTP binding
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Normal Normal Functional hyposplenism,
recurrent bacterial, and viral
infections, recurrent episodes
of encephalopathy and liver
dysfunction. Defective
lymphocyte apoptosis
AR Mutations in FADD encoding
an adaptor molecule


















enamel hypoplasia, and other
abnormalities
AR Mutations in AIRE, encoding
a transcription regulator























XL Mutations in FOXP3,
































chronic lung disease, failure
to thrive, developmental
delay, macrocephaly
AR Mutations in ITCH,a nE 3
ubiquitin ligase
613385
XL, X-linked inheritance; AR, autosomal recessive inheritance; AD, autosomal dominant inheritance; DN, double negative; SL, systemic lupus erythematosus.
*Ten or fewer unrelated cases reported in the literature.
STXBP2/Munc18-2 deﬁciency has been added as the cause of “FHL5,” a new form of FHL. Of note, “FHL1” has not yet received a genetic/molecular identiﬁcation.
FADD deﬁciency is classiﬁed among the causes of ALPS. It should be stressed however that FADD deﬁciency is a more complex syndrome that encompasses
hyposplenism, hence bacterial infections, as well as a brain and liver primary dysfunction. EBV-driven lymphoproliferation is also observed in ITK deﬁciency and in
MAGT1 deﬁciency (Table 1).
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AD ELANE: misfolded protein
response
202700













defects in some patients










venous angiectasis of trunks
and limbs























N ? Oscillations in the number of
other leukocytes and platelets
















































Poikiloderma, MDS AR C16orf57 gene: Pg unknown 604173












Delayed cord separation, skin
ulcers periodontitis
leukocytosis
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Mild LAD type 1 features plus
hh-blood group plus mental
and growth retardation









LAD type 1 plus bleeding
tendency
AR KINDLIN3:















N+M Motility Mental retardation, short
stature











N+M Chemotaxis Periodontitis, palmoplantar
hyperkeratosis in some
patients
AR CTSC: cathepsin C: abnormal




N Chemotaxis Neutrophils with bilobed
nuclei






N Chemotaxis Pancytopenia, exocrine
pancreatic insufﬁciency,
chondrodysplasia
AR SBDS: defective ribosome
synthesis
260400










extending into the contiguous
Kell locus









AR CYBA: electron transport protein
(p22phox)
NCF1: adapter protein (p47phox)
NCF2: activating protein
(p67phox)
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M+L IFN-γsignaling Susceptibility to Mycobacteria
and Salmonella






M+L IFN-γsignaling Susceptibility to
Mycobacteria, Salmonella









XL CYBB: electron transport





















































XL, X-linked inheritance; AR, autosomal recessive inheritance; AD, autosomal dominant inheritance; ACTB, actin beta; B, B-lymphocytes; CEBPE, CCAAT/enhancer-
binding protein epsilon; CMML, chronic myelomonocytic leukaemia; CTSC, cathepsin C; CYBA, cytochrome b alpha subunit; CYBB, cytochrome b beta subunit;
DC, dendritic cells; ELANE, elastase neutrophil-expressed; GATA2, GATA binding protein 2; IFN, interferon; IFNGR1, interferon-gamma receptor subunit 1; IFNGR2,
interferon-gamma receptor subunit 2; IL12B, interleukin-12 beta subunit; IL12RB1, interleukin-12 receptor beta 1; IFR8, interferon regulatory factor 8; F , ﬁbroblasts;
FPR1, formyl peptide receptor 1; FUCT1, fucose transporter 1; GFI1, growth factor independent 1; HAX1, HLCS1-associated protein X1; ITGB2, integrin beta-2; L,
lymphocytes; M, monocytes–macrophages; MDC, myeloid dendritic cells; MDS, myelodysplasia; Mel, melanocytes; Mφ, macrophages; MSMD, Mendelian suscepti-
bility to mycobacterial disease; N, neutrophils; NCF1, neutrophil cytosolic factor 1; NCF2, neutrophil cytosolic factor 2; NCF4, neutrophil cytosolic factor 4; NK, natural
killer cells; ROBLD3, roadblock domain containing 3; SBDS, Shwachman–Bodian–Diamond syndrome; STAT, signal transducer and activator of transcription.
*Ten or fewer unrelated cases reported in the literature.
Table 5 includes seven newly described genetic defects of phagocyte number and/or function including Barth syndrome, Cohen syndrome and Poikiloderma with
neutropenia. In these three clinically well-known diseases the genetic defects have been elucidated, although their molecular pathogenesis remains ill-deﬁned. A
new cause of autosomal recessive chronic granulomatous disease, namely a deﬁciency of the cytosolic activating protein p40 phox, has now been found in two CGD
patients and is included under defects of respiratory burst. Under the heading of Mendelian susceptibility of mycobacterial disease (MSMD) two new entities were
added: a) a subgroup of X-linked gp91 phox deﬁciency with isolated susceptibility to mycobacteria and a defect of the respiratory burst in macrophages only; b) an
autosomal dominant form of IRF8 deﬁciency, resulting from a lack of CD1c
+ myeloid dendritic cells that would normally secrete IL12.The clinical phenotype of MSMD
may vary, depending on the nature of the genetic defect. Finally GATA2 deﬁciency was recently identiﬁed as the cause of the Mono MAC syndrome, with multilineage
cytopenias (of monocytes, peripheral dendritic cells, NK- and B-lymphocytes) resulting in opportunistic infections (including mycobacteria), alveolar proteinosis and
malignancy.
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Table 6 | Defects in innate immunity.
Disease Affected cell Functional
defect




















XL Mutations of NEMO (IKBKG),















AD Gain-of-function mutation of























AR Mutation of MYD88, a




















reduced B cell number,
severe reduction of neutrophil
count, warts/HPV infection
AD Gain-of-function mutations of








Human Papilloma virus (group
B1) infections and cancer of
the skin
AR Mutations of EVER1, EVER2 226400








IFN-α,- β, and -λ
induction
Herpes simplex virus 1
encephalitis










Herpes simplex virus 1
encephalitis







IFN-α,- β, and -λ
induction












AR Mutations of CARD9 212050









CMC AR Mutation in IL-17RA 605461
(b) IL -17F
deﬁciency*
T cells IL -17F-containing
dimers
CMC AD Mutation in IL-17F 606496
(Continued)
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Table 6 | Continued
Disease Affected cell Functional
defect












CMC AD Mutations in STAT 1 614162
9.Trypanoso-
miasis*
APOL -I Trypanosomiasis AD Mutation in APOL -I 603743
XL, X-linked inheritance; AR, autosomal recessive inheritance; AD, autosomal dominant inheritance; NF-κB, nuclear factor κ B;TIR, toll and interleukin 1 receptor; IFN,
interferon; HP , human papilloma virus;TLR, toll-like receptor; IL: interleukin.
*Ten or fewer unrelated cases reported in the literature.
Four new disorders have been added toTable 6. AD TRAF3 deﬁciency is a new genetic etiology of HSE that has been diagnosed in a single patient. A new entry
in theTable is CMC, for which three genetic etiologies have been discovered. AR IL -17RA deﬁciency and AD IL -17F deﬁciency have been found in one kindred each.
Gain-of-function mutations in STAT1 have been found in over 50 patients with AD CMC.The mechanism of CMC in these patients involves impaired development of
IL -17-producingT cells, due to the hyperactivity of STAT1-dependent signals.
XR-EDA-ID is highly heterogeneous clinically, both in terms of developmental features (some patients display osteopetrosis and lymphedema, in addition to EDA,
while others do not display any developmental features) and infectious diseases (some display multiple infections, viral, fungal, and bacterial, while others display a
single type of infection).The various OMIM entries correspond to these distinct clinical diseases.
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Table 7 |Autoinﬂammatory disorders.

















Decreased production of pyrin






























Defect in cryopyrin, involved
in leukocyte apoptosis and














same as above Non-pruritic urticaria,


















same as above Neonatal onset rash,
chronic meningitis, and















or diminished soluble cytokine
receptor available to bindTNF
Recurrent fever, serositis,












Mutation in IL -10 or IL -10
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Table 7 | Continued









(d) Blau syndrome Monocytes Mutations in nucleotide






































Mutations in the IL1 receptor
antagonist allows unopposed
action of interleukin 1






AR, autosomal recessive inheritance; AD, autosomal dominant inheritance; PMN, polymorphonuclear cells; ASC, apoptosis-associated speck-like protein with a cas-
pase recruitment domain; CARD, caspase recruitment domain; CD2BP1, CD2 binding protein 1; PSTPIP1, proline/serine/threonine phosphatase-interacting protein
1; SNHL, sensorineural hearing loss; CIAS1, cold-induced autoinﬂammatory syndrome 1.
*Ten or fewer unrelated cases reported in the literature.
Autoinﬂammatory diseases are clinical disorders marked by abnormally increased inﬂammation, mediated predominantly by the cells and molecules of the innate
immune system, with a signiﬁcant host predisposition. While the genetic defect of one of the most common autoinﬂammatory conditions, PFAPA, is not known,
recent studies suggest that it is associated with activation of IL -1 pathway and response to IL -1 beta antagonists.
Muckle–Wells syndrome, familial cold autoinﬂammatory syndrome, and neonatal onset multisystem inﬂammatory disease (NOMID) which is also called chronic
infantile neurologic cutaneous and articular syndrome (CINCA) are caused by similar mutations in CIAS1 mutations.The disease phenotype in any individual appears
to depend on modifying effects of other genes and environmental factors.
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C1q deﬁciency Absent CH50 hemolytic






AR Mutations in C1QA, C1QB,





C1r deﬁciency Absent CH50 hemolytic






AR Mutations in C1r and loss of
early complement activation
216950




AR Mutations in C1s and loss of
early complement activation
120580
C4 deﬁciency Absent CH50 hemolytic







disease, infections C4A; homozygous;
SLE, type I diabetes C4B:
homozygous: bacterial meningitis
AR Mutations in C4A and C4B




C2 deﬁciency Absent CH50 hemolytic






AR Mutations in C2 and loss of
early complement activation
217000





Life threatening pyogenic infections;
SLE-like disease; glomerulonephritis;
atypical hemolytic–uremic syndrome;
selected SNPs with age related
macular degeneration









Neisserial infections, SLE AR Mutations in C5α?o rC5β?
and loss of complement
activation
120900




Neisserial infections, SLE AR Mutations in C6 and loss of
complement activation
217050





























association than in C5, C6, C7 , or C8
deﬁciency
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Spontaneous activation of the
complement pathway with
consumption of C4/C2,
spontaneous activation of the
contact system with
generation of bradykinin from
high molecular weight
kininogen
Hereditary angioedema AD Mutations in C1 inhibitor and






















Spontaneous activation of the
alternative complement












Spontaneous activation of the
alternative complement





infections; selected SNPS: severe
pre-eclampsia
AR Mutations in factor H(CFH),
leading to continuous
activation of the alternative





Potential loss of embryonic
cell migration signals
A developmental syndrome of facial
dysmorphism, cleft lip, and/or palate,
craniosynostosis, learning disability
and genital, limb and vesicorenal
anomalies









Potential loss of embryonic
cell migration signals
A developmental syndrome of facial
dysmorphism, cleft lip and/or palate,
craniosynostosis, learning disability
and genital, limb and vesicorenal
anomalies
AR Gene product CL -K1, a C-type





Absent hemolytic activity by
the lectin pathway
Pyogenic infections; inﬂammatory lung
disease



















AD Mutations in MCP leading to
loss of the cofactor activity
needed for the factor









Hemolytic anemia, thrombosis AR Mutations in CD59 leading to
loss of this membrane
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abdominal pain, smooth muscle




Disease results from the
expansion of hematopoietic
stem cells bearing mutations
in PIGA and subsequent loss
of biosynthesis of
glycosylphosphatidylinositol
(GPI) a moiety that attaches







activation by the Ficolin 3
pathway.
Recurrent severe pyogenic infections
mainly in the lungs; necrotizing
enterocolitis in infancy; selective
antibody defect to pneumococcal
polysaccharides




XL, X-linked inheritance; AR, autosomal recessive inheritance; AD, autosomal dominant inheritance; MAC, membrane attack complex; SLE, systemic lupus erythe-
matosus; MBP , Mannose binding Protein; MASP2, MBP associated serine protease 2.
*Ten or fewer unrelated cases reported in the literature.
New entities added toTable 8 demonstrate the important role of complement regulators in a group of well-described inﬂammatory disorders. In particular, we have
added mutations in membrane bound as well as surface attached soluble complement regulatory proteins recognized in hemolytic–uremic syndrome, age related
macular degeneration and pre-eclampsia.The connecting theme of these otherwise unrelated clinical events is excessive activation or insufﬁcient regulation of C3;
these events lead to recruitment of leukocytes and permit secretion of inﬂammatory and anti-angiogenic mediators that disrupt the vascular bed of the target organ.
Alterations in the genes for factor B (CFB), factor I (CFI), factor H (CFH), and CD46 act as susceptibility genes rather than disease causing mutations. Population
studies reveal no detectable increase in infections in MBP (also known at mannose binding lectin – MBL) deﬁcient adults. The 3MC syndrome, a developmental
syndrome, has been variously called Carnevale, Mingarelli, Malpuech, and Michels syndrome.
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